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Abstract
Background: The acid-ash hypothesis posits that increased excretion of "acidic" ions derived
from the diet, such as phosphate, contributes to net acidic ion excretion, urine calcium excretion,
demineralization of bone, and osteoporosis. The public is advised by various media to follow an
alkaline diet to lower their acidic ion intakes. The objectives of this meta-analysis were to quantify
the contribution of phosphate to bone loss in healthy adult subjects; specifically, a) to assess the
effect of supplemental dietary phosphate on urine calcium, calcium balance, and markers of bone
metabolism; and to assess whether these affects are altered by the b) level of calcium intake, c) the
degree of protonation of the phosphate.
Methods: Literature was identified through computerized searches regarding phosphate with
surrogate and/or direct markers of bone health, and was assessed for methodological quality.
Multiple linear regression analyses, weighted for sample size, were used to combine the study
results. Tests of interaction included stratification by calcium intake and degree of protonation of
the phosphate supplement.
Results:  Twelve studies including 30 intervention arms manipulated 269 subjects' phosphate
intakes. Three studies reported net acid excretion. All of the meta-analyses demonstrated
significant decreases in urine calcium excretion in response to phosphate supplements whether the
calcium intake was high or low, regardless of the degree of protonation of the phosphate
supplement. None of the meta-analyses revealed lower calcium balance in response to increased
phosphate intakes, whether the calcium intake was high or low, or the composition of the
phosphate supplement.
Conclusion: All of the findings from this meta-analysis were contrary to the acid ash hypothesis.
Higher phosphate intakes were associated with decreased urine calcium and increased calcium
retention. This meta-analysis did not find evidence that phosphate intake contributes to
demineralization of bone or to bone calcium excretion in the urine. Dietary advice that dairy
products, meats, and grains are detrimental to bone health due to "acidic" phosphate content needs
reassessment. There is no evidence that higher phosphate intakes are detrimental to bone health.
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Background
Phosphate is generously supplied in the diet through
meat, grains and dairy products, and increasingly in recent
decades, it is added to foods as food additives [1]. How-
ever, the understanding of dietary phosphate's role on
bone health is not clear. While phosphate is a fundamen-
tal mineral component of hydroxyapatite, the principal
structural element of bone, the acid-ash hypothesis posits
that dietary phosphate, a marker of the metabolic produc-
tion of acid, is detrimental to bone [2-4].
According to this acid-ash hypothesis, "acidic" ions such
as phosphate contribute to the diet acid load (referred to
as the renal acid load) which then the skeleton buffers,
causing demineralization of bone, and bone calcium
excretion in the urine, contributing to osteoporosis [2-4].
The acid-ash hypothesis proposes that the modern diet
causes osteoporosis since the quantity of "acidic" ions
(phosphate (PO4
---), sulfate (SO4
--), chloride (Cl-) in the
diet is greater than the quantity of "alkaline" ions (sodium
(Na+), potassium (K+), calcium (Ca++), and magnesium
(Mg++)) [2-4]. Under the hypothesis, these ions are
summed in the following equation to predict the poten-
tial renal acid load of the diet: (1.8PO4
--- + SO4
-- + Cl-) -
(Na+ + K+ + 2Ca++ + 2 Mg++) [2].
Phosphate is considered to be the major dietary source of
acid [2]. Many foods in the modern diet are considered
detrimental to bone health, under the acid-ash hypothe-
sis, due partially to their phosphate contents. These foods
include meats, fish, dairy products [2,5-10], and grains
[3,4,10], as well as many processed foods [3,4,10]. In con-
trast, this hypothesis posits that sodium is protective of
bone health, which is not in agreement with concerns that
sodium may compete with calcium for resorption in the
kidney, and thus may compromise calcium metabolism
and bone health [11,12]. The foods that are considered to
protect skeletal mineral under this hypothesis are fruit
and vegetables since these foods supply organic molecules
that are metabolized to bicarbonate and therefore are con-
sidered "alkaline" [2-4,10,13,14].
Although the acid-ash hypothesis has been widely
accepted and broadly stated as the major modifiable risk
factor for bone loss in well cited scientific papers [4,15], as
well as textbooks [16], reference works [17,18], and lay lit-
erature, this hypothesis has not been subjected to critical
review. In spite of the lack of critical review, this hypothe-
sis is heavily promoted to the public via the internet and
other advertising for commercial gain, promoting prod-
ucts related to an alkaline diet.
The quantity of excess urinary calcium excretion associ-
ated with the acid-load of the modern diet is of sufficient
quantity that could, if it is not accompanied by decreased
fecal calcium losses, lead to the bone mineral loss of oste-
oporosis [19]. However, acid-generating diets are not det-
rimental to whole body calcium balance [20]. This recent
finding [20] raises doubt about the acid-ash hypothesis
which raises the additional question of whether an acid
load from phosphate contributes to the excretion of bone
calcium and the development of osteoporosis.
Additional variables may influence the relationship
between dietary phosphate intakes and bone health. Cal-
cium intakes, that is whether calcium intakes are limited
or insufficient, might influence the relationship between
phosphate, the diet acid load, and bone health [21,22]. As
well, the general concept of the acid-ash hypothesis is
based on the "acidity" of the diet, therefore the degree of
protonation of the ions in the foods (e.g. H3PO4 versus
Na2HPO4) may be of importance. A meta-analysis pro-
vides an opportunity to assess these issues.
The purpose of this study is to use the techniques of meta-
analysis to quantify the potential contribution of dietary
phosphate to bone health, as measured by surrogate and,
if possible, direct measures of this osteoporosis. Second, it
will assess whether these effects are altered by the level of
calcium intake of the subjects and by the degree of proto-
nation of the phosphate supplements.
Methods
Literature search for the systematic review
Literature relating to intervention studies of dietary phos-
phate supplementation on calcium metabolism was iden-
tified through computerized searches. We used four
comprehensive search themes based on keywords/text-
words, which were combined using the Boolean operators
"OR" within the themes and then "OR" and "AND" to
combine the themes. The themes were related to phos-
phate (phosphorus, phosphate, phosphates), acid excre-
tion (net acid excretion, acid excretion, acid-base
equilibrium), and the outcomes: bone health (bone,
bones, bone density, bone mineral density, fractures,
biopsy, bone resorption markers), or calcium metabolism
and excretion (calcium, calcium, calciuria, excretion,
urine, urinary, balance, retention). The search was limited
to adults 19+ years, with no upper age limit. Databases
searched included Medline back to 1966 (OVID and
PubMed), Cochrane Database of Systematic Reviews,
CINAHL back to 1982, EMBASE back to 1980, the
Cochrane Controlled Trials Register, and http://
www.ClinicalTrials.gov, all up to January 2009. We devel-
oped our search strategy in PubMed and modified it for
use in other databases. The literature search was not lim-
ited to English language articles. Reference lists were
reviewed for additional relevant studies.Nutrition Journal 2009, 8:41 http://www.nutritionj.com/content/8/1/41
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Selection criteria for the literature
Intervention studies were included if they manipulated
human subjects' dietary phosphate intake through sup-
plemental phosphate salts and reported outcomes related
to bone health, urinary calcium excretion, and/or calcium
balance in healthy adult subjects. Outcomes related to
bone health included: bone biopsy, change of bone min-
eral density (BMD) or fractures, bone resorption markers.
Since the aim of this meta-analysis was to study the poten-
tial for the acid-ash diet hypothesis to have a role in the
development of osteoporosis in apparently healthy
adults, studies were restricted to adult subjects. We
excluded studies of subjects with chronic conditions such
as renal disease or conditions which could alter calcium
absorption or excretion such as inflammatory bowel dis-
ease, cancer, weight loss, or decreased ambulation. Stud-
ies with an observational design were not included since
they were likely to have confounded effects due to changes
in protein, energy or calcium intakes, since these nutrients
are correlated with phosphate in foods. Calcium balance
was defined as calcium intake minus excretion (urinary
plus fecal) [23].
Methodological quality
We evaluated the studies' methodological quality in terms
of whether the guidelines for calcium balance studies by
the Institute of Medicine [24] were followed and whether
the subjects were randomized to the interventions
[25,26]. The Institute of Medicine recommends calcium
balance studies control the subjects' calcium intakes for
the seven or more days prior to measurement of the out-
comes, provide of all the food to subjects, accurately
measure the amounts of food consumed, and perform
laboratory analysis to determine the calcium composition
of the foods [24].
Statistical Analyses
Multiple linear regression analyses were conducted to
examine the effect of increased daily dietary phosphate on
urinary calcium excretion, calcium balance, and markers
of bone resorption or turnover (i.e., the percent changes
of hydroxyproline and N-terminal telopeptide of Type I
collagen). Interaction terms were included in the regres-
sion models to test the hypothesis that the estimated
effects of the phosphate supplements were the same
whether the subjects were on high or low calcium intakes
or whether the phosphate supplement was acidic or not.
The following variables were included in all the models to
adjust for differences among the studies: age, gender,
whether the studies were randomized, baseline phosphate
intakes, and duration of the balance studies (Table 1 and
Table 2). One study did not report the age of their sub-
jects, who they described as "young women" and the
median age of 22 was assumed to keep this study in the
model. The analyses were weighted for study sample size.
The cut-point used to stratify the analysis by calcium
intake was an intake greater than or equal to versus less
than that intake considered adequate by the Institute of
Medicine of 1000 mg/day (25 mmol/day) for adults aged
19 through 50 years; 1200 mg/day (30 mmol/day) for
those aged 51 or older [24]. Phosphate supplements were
Table 1: Included studies in the meta-analysis of calcium balance from a change of phosphate intake
Study Year Subjects Age 
range 
(years)
% female Study 
design
Baseline
PO4 
intake 
(mmol/
day)
Ethics 
approval
Food 
weighted 
Food lab 
analysis
Usual 
Calcium 
intake
Patton [21] 1953 young women N/A (100%) RCO 25 N/A yes yes no
Malm [27] 1953 male prisoners 20-56 0 CO unclear N/A yes yes yes
Goldsmith 
[28]
1976 postmenopausal 
women with 
osteoporosis
63-75 7(100%) CO 40 N/A no no yes
Bell [29] 1977 young adults 24-36 3/8 (38%) CO 32 yes yes yes no
Spencer 
[30]
1978 adult men 38-65 0 CO 25 N/A yes yes no
Hegsted 
[31]
1981 adult males 19-25 0 CO 33 yes yes yes no
Zemel [32] 1981 young men 18-24 0 CO 27 yes yes yes no
Schuette 
[33]
1982 young men 19-26 0 CO 29 yes yes yes no
Spencer 
[34]
1986 adult males 48-71 0 CO 26 yes yes yes no
Whybro 
[36]
1998 healthy men 19-38 0 RCO 26 & 32 yes no no no
Kemi [37] 2006 young women 20-28 48(100%) RCO 16 yes no no no
Krapf [35] 1995 young men 22 0 CO 49 yes no no noNutrition Journal 2009, 8:41 http://www.nutritionj.com/content/8/1/41
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Table 2: Study arm calcium intakes, phosphate doses, urine calcium and calcium balance
Study n Phosphate 
dose 
(mmol/day)
Phosphate source Calcium 
Intake 
(mmol/day)
Days on 
Calcium 
intake*
Days on each 
balance study 
after 
adaption**
Change 
uCalcium 
(mmol/day)
Change 
Calcium 
balance 
(mmol/day)
Patton [21] 18 10 Na2HPO4 & Na 
glycerophosphate
977- 0 . 4 - 0 . 2
Patton [21] 18 19 " 9 7 7 -1.0 0.6
Patton [21] 18 10 " 24 7 7 -0.4 -0.6
Patton [21] 18 19 " 24 7 7 -1.5 0.3
Patton [21] 18 10 " 39 7 7 -1.0 0.03
Patton [21] 18 19 " 39 7 7 -0.4 1.1
Malm [27] 4 24 H3PO4 - 98 7 -0.9 n/a
Malm [27] 2 32 H3PO4 11 98 28 -0.7 0.7
Malm [27] 4 26 H3PO4 20 98 28 -0.9 0.1
Malm [27] 2 19 H3PO4 13 56 56 -1 0.03
Goldsmith 
[28]
7(4) 32 K2H & KH2 21 7 4 -0.9 0.45
Bell [29] 5 37 Na PolyP 18 6 22 -1.7 n/a
Spencer 
[30]
10 37 Naglycerophosphate 5 0 22 -0.8 0.03
Spencer 
[30]
8 37 Naglycerophosphate 21 0 40 -1.7 0.70
Spencer 
[30]
3 39 Naglycerophosphate 36 0 34 -2.3 -0.35
Spencer 
[30]
6 36 Naglycerophosphate 50 0 31 -2.1 0.10
Hegsted 
[31]
8 49 KH+PO+ 13 0 12 -2.5 0.94
Zemel [32] 8 32 KH2PO4 10 2 11 -2.0 2.7
Zemel [32] 8 32 (NaPO3)6 10 2 11 -2.0 1.3
Schuette 
[33]
82 5 K H 2PO4 15 2 6 -0.9 0.03
Spencer 
[34]
1 35 Naglycerophosphate 6 0 66 -3.2 0.5
Spencer 
[34]
4 34 Naglycerophosphate 20 0 42 -3.0 1.3
Spencer 
[34]
2 41 Naglycerophosphate 34 0 33 -3.6 0.00Nutrition Journal 2009, 8:41 http://www.nutritionj.com/content/8/1/41
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stratified into acidic (e.g. H3PO4) or neutral/alkaline (e.g.
Na2HPO4) categories. Stata, Version 10.1 (StataCorp, Col-
lege Station, Texas, USA), was used for the data analyses.
Results
Description of studies
The literature search identified 32 dietary phosphate inter-
vention studies. Twelve of the studies met all the inclusion
criteria [21,27-37] (Table 1). Studies not included used
study periods of less than 24 hours [38-42]; had more
than one intervention performed [43-51]; reported no
numerical results in the paper or in response to a written
request [52-54]; had an observational design [55-57]; or
the subjects had chronic conditions [22,58,59]. No non-
English language papers met the criteria for acceptance.
All of the included studies except one arm within one
study [27] noted that calcium intakes were controlled.
One study used postmenopausal women with osteoporo-
sis as the subjects, and they described these patients as
having "roentgenographic and clinical diagnoses" of oste-
oporosis [28]. One study [31] had other outcomes
reported in a second paper [6]. Phosphate was supple-
mented in all of the studies by providing a daily dietary
phosphate salt (Table 2), and some provided some addi-
tional sodium with the phosphate. Two studies [32,35]
controlled for changes in sodium intake from the phos-
phate supplement by reducing NaCl when the sodium
and phosphate were provided. The subjects consumed
their usual calcium intakes in two studies [27,28] while
the other subjects consumed a specified calcium intake for
zero to 14 days prior to collecting outcome data. Eight of
the 12 studies weighted the food intake of the subjects and
analyzed identical portions for calcium content (Table 1).
Methodological quality
Only one of the studies used superior methodology: using
both randomization [25,26] and the Institute of Medi-
cine's recommendations for calcium balance studies [21]
(Tables 1 &2).
Study Outcomes
None of the phosphate supplementation studies assessed
bone related outcomes such as changes in BMD, as meas-
ured using absorptiometry, or the incidence of fractures.
One study [28] included changes in BMD as measured
using bone biopsies of the subjects while on supplemen-
tal phosphate, but did not report biopsy results during the
control phase.
Eleven studies assessed the effect of supplemental dietary
phosphate salts administered orally, while one adminis-
tered the phosphate intravenously [35], on urine calcium
over 24-hours in healthy adults [21,27-34,36,37]. Eight of
the studies examined calcium balance over one to 66 days
[21,27,28,30-34] and one assessed calcium balance
among only four of the seven subjects [28]. Six studies
examined the effect of dietary phosphate supplements on
bone turnover markers [29,31-33,36,37].
As the present study was designed to examine conditions
similar to the modern diet, we did not include two inter-
vention arms (one arm in each of two studies [30,34]), as
the subjects were given very high calcium intakes (2700 &
2600 mg/day, 68 & 65 mmol/day). These are greater than
the Tolerable Upper Limit of the Institute of Medicine
Dietary Reference Intake for calcium [24], and therefore
we considered them experimental. The remaining 30
intervention arms had outcomes related to calcium excre-
tion, calcium balance and/or markers of bone metabolism
among 269 subjects (Table 1 and 2).
Spencer 
[34]
3 40 Naglycerophosphate 51 0 40 -3.5 0.2
Whybro 
[36]
93 2 N a H 2PO4 25 5 2 -1.1 n/a
Whybro 
[36]
11 48 Not stated 25 5 9 -2.4 n/a
Kemi [37] 14 8 Na2 Na3 HPO4 6 0 1 -0.2 n/a
Kemi [37] 14 24 Na2 Na3 HPO4 6 0 1 -0.5 n/a
Kemi [37] 14 48 Na2 Na3 HPO4 6 0 1 -0.5 n/a
Krapf [35] 6 9.6 IV PO4 vs Cl 35 4 3 -3.5 n/a
* days on calcium intake prior to the measurement of outcomes
** the shortest number of days on the balance study is reported if it varied within the comparison interventions
Table 2: Study arm calcium intakes, phosphate doses, urine calcium and calcium balance (Continued)Nutrition Journal 2009, 8:41 http://www.nutritionj.com/content/8/1/41
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Results from the individual studies
All 30 interventions that increased dietary phosphate
intake showed a decrease in urine calcium; 16 of these
changes were statistically significant [28-37], six were not
significant [27,34], six interventions in one study did not
report statistical significance nor information that permit-
ted statistical testing [21]. Of the 22 interventions of cal-
cium balance, only one study [32] demonstrated a
significant change in calcium balance from the phosphate
supplement. The direction of this effect was a statistically
significant increase in calcium retention in response to the
dietary phosphate supplement [32]. Only three of the
studies reported the change of net acid excretion in
response to the phosphate supplements [6,31,33,35]. All
three studies noted increases in net acid excretion (45, 21,
and 41 mEq/day) in response to the phosphate supple-
ments of 49, 25, and 10 mmol/day, respectively.
The hydroxyproline results in the individual studies in
response to phosphate supplementation were as follows:
Bell reported a significant increase in hydroxyproline of
20% (p < 0.0001) [29], while three studies reported non-
significant decreases between 5 and 20% [31-33]. For the
N-telopeptide results, in response to the phosphate sup-
plements, both Whybro et al and Kemi et al saw non-sig-
nificant changes from baseline (-1.5%, -5.3%, and 29%)
[36,37].
Regression analysis
The multiple regression analyses results are summarized
in Table 3 and illustrated in the Figures.
Urine calcium decreased as phosphate doses increased,
regardless of calcium intakes. For both low and high cal-
cium intakes, higher phosphate supplements led to signif-
icantly lower urine calcium excretion (Figure 1, Table 3, p
= 0.001). The test of interaction, which assessed whether
the effect of the phosphate supplement on urine calcium
differed by calcium intakes of the subjects, revealed that
the change (slope) in urine calcium was not significantly
different when the calcium intakes were greater or less
than the recommended intakes (p = 0.19). There was a
slight difference in the quantity of urine calcium, between
those on low versus high calcium intakes (Figure 1).
In contrast, for both low and high calcium intakes, higher
phosphate supplements led to significantly greater cal-
cium balance (Figure 2, Table 3, p < 0.001). The test of
interaction, which assessed whether the effect of the phos-
phate supplement differed by calcium intakes of the sub-
jects, revealed that the change (slope) in calcium balance
was not significantly different when the calcium intakes
were greater or less than the recommended intakes (p =
0.82). There was no apparent difference in the quantity of
calcium balance between those on low versus high cal-
cium intakes (Figure 2).
Urine calcium decreased as phosphate doses increased,
whether the phosphate supplement was neutral/alkaline
versus acidic (Figure 3, Table 3). When the phosphate sup-
plement was neutral/alkaline, urine calcium decreased by
0.008 mmol/day for every mmol/day increase of phos-
phate dose (p = 0.037). The magnitude of change of urine
calcium in response to the phosphate was significantly
greater if the phosphate was an acidic salt (p < 0.001).
Urine calcium decreased by 0.07 mmol/day for every
mmol/day of phosphate supplement, when the phos-
phate was acidic (p < 0.001).
The effect of the degree of protonation of the phosphate
supplements altered their effect on calcium balance (Fig-
ure 4, Table 3). When the phosphate supplement was neu-
tral/alkaline, calcium balance increased by 0.086 mmol/
day for every mmol of phosphate supplement (p < 0.001).
Table 3: Regression analysis results
Urine calcium Calcium balance
Analysis B1 p-value for slope p-value for 
interaction
R2 B1 p-value for slope p-value for 
interaction
R2
Low calcium intakes 
(B1)
-0.012 0.001 0.19 0.612 0.048 < 0.001 0.82 0.390
High calcium intakes -0.012 0.048
Neutral or alkaline 
phosphate supplement 
(B1)
-0.008 0.037 < 0.001 0.645 0.086 < 0.001 < 0.001 0.457
Acidic phosphate 
supplement
-0.070 < 0.001 0.008 0.78
B1 = slope coefficient from regression model
R2 = the proportion of variance explained by the regression analysisNutrition Journal 2009, 8:41 http://www.nutritionj.com/content/8/1/41
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The magnitude of change of calcium balance was signifi-
cantly less when the phosphate was provided as an acidic
salt (p < 0.001). Calcium balance increased non-signifi-
cantly, by 0.008 mmol/day for every mmol/day of phos-
phate supplement, when the phosphate was acidic (p =
0.78).
As there were very few studies and the change of phos-
phate intake on the change of bone turnover markers,
hydroxyproline and N-terminal telopeptide, did not
appear to have straight line relationships, no attempt was
made to combine these data in regression analyses (Fig-
ures 5 and 6).
Discussion
All four of the urine calcium meta-analyses demonstrated
that when dietary phosphate was increased, urine calcium
decreased, whether the subjects had low or high calcium
intakes and whether the phosphate supplement was neu-
tral/alkaline or acidic. Three of the four calcium balance
analyses revealed that as phosphate supplements are
increased, calcium balance increased. However, when the
phosphate salt was acidic, there was no important change
in calcium balance. The effect of phosphate supplementa-
tion on the bone metabolism markers did not provide any
clear information. The increased net acid excretion from
phosphate supplements in three studies was associated
with lowered urinary calcium excretion.
All of the findings of this study contradict the acid ash
hypothesis since the hypothesis posits that an "acidic" ion
such as phosphate causes increased urinary excretion of
bone calcium, and therefore calcium balance would be
decreased by phosphate. None of the study findings sup-
port the hypothesis since phosphate supplements did not
increase urine calcium or decrease calcium balance. Die-
Phosphate and change in urine calcium stratified by calcium intakes: Slope = -0.021 p = 0.001. Low calcium intakes: ------; High  calcium intakes: ______ Figure 1
Phosphate and change in urine calcium stratified by calcium intakes: Slope = -0.021 p = 0.001. Low calcium 
intakes: ------; High calcium intakes: ______.
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tary phosphate is considered to be the major source of
excreted acid, followed by sulfate derived from protein
[2]. However, this current study contradicts the assertion
that dietary phosphate is detrimental to bone, and our
previous work contradicts the assertion that protein is det-
rimental to bone [20]. When the evidence regarding the
acid-ash hypothesis is critically examined, there is more
contradiction than support for the hypothesis.
Most of the evidence in favor of the acid-ash hypothesis is
based on the outcomes of changes of urinary calcium and
changes of indicators of mineral metabolism or bone
turnover markers [2,6,8,9,15,31,60-64]. However, urinary
calcium and bone/mineral markers, are not direct meas-
ures of osteoporosis. Changes in urine calcium excretion
are poor surrogate measures of bone health, as intestinal
calcium absorption [65] and/or secretion [66] may also be
altered by an intervention. Calcium balance changes are
much better measures of changes of calcium status than
changes of urinary calcium, and calcium balance studies
can provide useful information about whole body cal-
cium metabolism when the studies are well designed [24].
What better bone health outcomes have studies used as to
test the association of the acid-ash hypothesis? The
National Institutes of Health Consensus Panel defined
Osteoporosis as ". a skeletal disorder characterized by
compromised bone strength predisposing a person to an
increased risk of fracture" [67]. The only currently availa-
ble measures that address bone strength are the occur-
rence of low trauma fractures and/or biomechanical
testing of bone biopsy material [68,69]. In the assessment
of pharmaceutical interventions for osteoporosis, fracture
prevention is considered the appropriate outcome meas-
ure for clinical trials, and not change in bone density. In
clinical practice, however, bone density is an objective
Phosphate and change in calcium balance, stratified by calcium intakes: Slope = -0.048 p < 001. Low calcium intakes: ------; High  calcium intakes: ______ Figure 2
Phosphate and change in calcium balance, stratified by calcium intakes: Slope = -0.048 p < 001. Low calcium 
intakes: ------; High calcium intakes: ______.
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measure often used for following an individual's response
to an intervention. Although low bone density is used in
the clinical diagnosis of osteoporosis, it is simply a risk
factor for bone fragility.
Two randomized controlled studies of the acid ash
hypothesis have used changes of BMD as the outcome
measure [70,71]. Both of these studies tested the BMD
response to potassium citrate [70,71] and one of these
studies also increased fruit and vegetable intakes in an
additional study arm [71]. The results of these studies
were opposite, one observed a decreased loss of spine
BMD among the potassium citrate arm [70], while in the
other study BMD change did not differ significantly
between study arms [71]. This discrepancy may be
explained by the use of allocation concealment, an indica-
tor of study rigor [72]. The latter study that saw no differ-
ences in BMD used adequate allocation concealment [71]
while the former study that saw a difference did not con-
ceal their allocation [70]. Inadequate allocation conceal-
ment is associated with an overestimation of effect [72],
therefore it is possible that the results from the former trial
[70] overestimated the effect of potassium citrate on bone.
Three prospective observational cohort studies found
some associations that appear to support the acid-ash
hypothesis, using changes in bone mineral density as the
outcome [73-75]. However, the three prospective studies
with positive associations had inconsistent findings, since
for each group in which a positive finding was identified
there were other subject groups and/or bone sites for
which the finding did not apply. The Framingham Oste-
oporosis study reported that in men potassium intake was
associated with loss of bone mineral density at the femo-
Phosphate and change in urine calcium, stratified by composition of phosphate supplements: Slope for acidic = -0.070 p <  0.001; slope for neutral/alkaline = -0.008 p = 0.037. Acidic phosphate supplement: ______; Neutral/alkaline phosphate supple- ment:------ Figure 3
Phosphate and change in urine calcium, stratified by composition of phosphate supplements: Slope for acidic = 
-0.070 p < 0.001; slope for neutral/alkaline = -0.008 p = 0.037. Acidic phosphate supplement: ______; Neutral/
alkaline phosphate supplement:------.
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ral neck and trochanter, but not at the radius, and there
were no associations found for women [74]. Fruit and
vegetable intakes were not significantly associated with
the changes of bone mineral density at any site for men or
women in this study [74]. Of 12 associations assessed in
this study regarding the acid-ash hypothesis, two were sig-
nificantly associated while 10 were not [74].
In the EPIC-Norfolk study, vitamin C was associated with
less loss of bone mineral density at the total hip among
elderly women but not among elderly men, and only after
the vitamin C intakes were divided into tertiles [75]. In the
Aberdeen Prospective Osteoporosis Screening study,
intakes of calcium and phosphorus (positively) and fat
(negatively) were associated more strongly with the loss of
bone mineral density over time than was potassium [73].
The two recent prospective cohort studies of the acid-ash
hypothesis used fractures as the outcome measure. Frac-
tures are considered a direct and clinically valid measure
of osteoporosis [68,69]. A study among 1865 vegetarian
and omnivorous peri- and postmenopausal women
found that the risk of wrist fracture decreased significantly
as protein intakes increased, whether the protein was from
plants or meat [76]. This study provides further support
for the concept that dietary protein is supportive of bone
health [77,78]. A French study among 36,217 women
examined the association between protein or the diet acid
load on fractures (excluded high trauma or metastases
fractures) found no overall support for the acid ash
hypothesis as neither protein nor the diet acid load were
associated with fracture risk [79]. However, in a subgroup
analysis, both higher protein intake and diet acid load
were associated with higher fracture risk among women in
Phosphate and change in calcium balance, stratified by composition of phosphate supplements: Slope for acidic = 0.008 p-value  = 0.78; slope for alkaline/neutral = 0.086 p-value < 0.001. Acidic phosphate supplement: ______; Neutral/alkaline phosphate  supplement:------ Figure 4
Phosphate and change in calcium balance, stratified by composition of phosphate supplements: Slope for 
acidic = 0.008 p-value = 0.78; slope for alkaline/neutral = 0.086 p-value < 0.001. Acidic phosphate supplement: 
______; Neutral/alkaline phosphate supplement:------.
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the lowest quartile of calcium intake [79]. In comparison,
in this meta-analysis we found no important differences
between phosphate intakes and calcium metabolism
between those with low or high calcium intakes. In sum-
mary, the findings from prospective cohort studies of the
acid-ash hypothesis of bone health demonstrated few
findings consistent with the hypothesis, and numerous
findings that did not support the hypothesis. It must be
remembered that observational studies do not have the
rigor of randomized control trials, and the findings from
observational studies can be confounded or confused by
other related variables. An example that might confound
observational studies of nutrition and bone health could
be due to those subjects who eat more fruit and vegetables
may also get more bone protective exercise.
The acid-ash hypothesis posits that meats, grains and
dairy products are detrimental to bone health due to their
phosphate contents [16,3,4,10], however, this meta-anal-
ysis revealed that higher dietary intakes of phosphate do
not increase either urinary calcium excretion or whole
body calcium loss. Further to question the acid ash
hypothesis, the evidence regarding higher net acid excre-
tion from changes in dietary protein type or amount does
not support the hypothesis [20]. No studies have evalu-
ated the effect of grain foods on bone health. Dairy prod-
ucts, an important source of dietary phosphate, are also an
important dietary calcium source [80] and an inexpensive
source of high quality protein. Protein has been found to
be supportive of bone health in a prospective cohort study
and a randomized controlled trial [77,78]. Considering
that this study has not upheld the concept that higher
intakes of phosphate are detrimental to bone mineral
maintenance, the consideration of meats, grains and dairy
products as detrimental to bone health on the basis of
their phosphate content must be questioned. Addition-
ally, these foods that produce acid on metabolism are
important sources of nutrients that are important for bone
Phosphate and change in markers of bone metabolism: Hydroxyproline Figure 5
Phosphate and change in markers of bone metabolism: Hydroxyproline.
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health, including calcium [81] (dairy products), protein
[82,83] (dairy products and meats), and vitamin D [84]
(some dairy products).
The recommendation for calcium balance studies by the
Institute of Medicine to have study subjects consume the
study calcium intake for at least a week prior to the out-
come measurement [24] is designed to allow the subjects
to adapt to the experimental calcium intake [24]. This
adaption to the study calcium intake is important to
lessen the chance that the adaption confuses or biases the
effect of the intervention. Randomization of the interven-
tions is very important in calcium balance cross-over stud-
ies since the adaptations to the calcium intake would be
uneven in the two arms of before-after non-randomized
cross-over studies.
Overall, the methodological quality of the studies of
phosphate supplementation was poor since only one of
the studies used superior methodology [21]: having rand-
omization and using all of the Institute of Medicine's rec-
ommendations for calcium balance studies. Therefore,
there is a chance that the results of the other studies are
biased due to poor methodology. The magnitude of this
bias would vary depending on whether the study calcium
intakes were greater or less than the subjects' usual
intakes. In spite of the questionable methodological qual-
ity, all of the other meta-analyses were in congruence with
the one study [21] that used superior methodology, which
suggests that the bias may not have been severe.
Concern has been raised about the phosphate, as well as
caffeine, contents of cola soft drinks and their potential
deleterious effects on bone health. Observational studies
that measured BMD [85] or asked subjects about previous
fractures [86] in relation to carbonated beverage intake
documented associations between these beverages and
poorer bone health. As well, a non-randomized cross-over
Phosphate and change in markers of bone metabolism: N-telopeptide Figure 6
Phosphate and change in markers of bone metabolism: N-telopeptide.
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intervention study identified higher bone resorption
markers from colas compared to milk [87]. The results
from this meta-analysis does not support the concept that
the phosphate in soda is deleterious, therefore, these
potentially deleterious effects could be due to lower milk
consumption, and therefore protein, calcium or other
nutrient intakes [87] since those that consume more car-
bonated beverage drink less milk [88,89], however gener-
alizations from the studies on soft drinks are limited by
the study designs used.
This meta-analysis has three strengths: First, this is the first
study to systematically assess the calcium balance litera-
ture in response to changes of phosphate supplementa-
tion. Second, this meta-analysis includes an evaluation of
methodological quality, and therefore an assessment of
potential confounding or bias. Third, the stratified analy-
ses allowed assessment of the effect of calcium intakes and
the degree of protonation of the phosphate supplement
on the findings.
This meta-analysis also has limitations. First, although
calcium balance is neither a direct measure of bone health
nor of the progression of osteoporosis, but rather it is a
surrogate measure of this disease progression. Therefore
this study lacks a direct measures of bone health. How-
ever, calcium balance is important since prolonged nega-
tive calcium balance leads to bone loss. Second, this study
is limited by the poor methodological quality of the
majority of the studies of phosphate intake on calcium
metabolism.
In conclusion, this meta-analysis revealed that raising
phosphate intakes decreases urine calcium and slightly
increases calcium retention over a broad range of calcium
intakes. This work does not support the acid-ash hypoth-
esis concepts that "acidic" ions such as phosphate contrib-
ute to demineralization of bone and bone calcium
excretion in the urine. A definitive study is needed that
follows all of the recommendations for methodological
quality for both calcium balance studies [24] as well as
recommendations for intervention studies [25,26], with
measurement of outcomes that are direct measures of
bone strength, to determine whether or not there is an
association between phosphate intake and osteoporosis.
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